TB-500: Evidence, Legal Status & Verified Clinics

TB-500 is a research peptide studied mostly in animal models for tissue repair. See what the evidence and 2026 legal status say, why it's banned in sport, and what to ask clinics that reference it. This page is informational and does not diagnose, prescribe, or recommend therapies.

Looking for clinics by city? Explore peptide clinics in Miami , Los Angeles, and New York to compare verified providers by treatment focus.

Recovery peptide users often compare BPC-157 and TB-500, while metabolic health users usually cross-reference semaglutide.

Common contexts

Frequently grouped with recovery support topics in directory listings.
Clinics may include it within broader performance pathways.
It is often referenced alongside BPC-157 in rehabilitation and soft-tissue recovery contexts.

Safety information

Discuss evidence quality, regulatory status, and alternatives with a licensed clinician.
Avoid clinics making guaranteed outcome claims.
Confirm that any clinic referencing TB-500 has a structured assessment and follow-up process.

Quick summary

TB-500 is a synthetic peptide related to a fragment of thymosin beta-4, a protein involved in cell movement and tissue repair; it is studied mainly in animal and laboratory research.
It is not an approved medicine. The UK's MHRA treats it as unlicensed, and in the US it is not FDA-approved, with no completed human efficacy trials.
TB-500 is prohibited in sport at all times by WADA, so any athlete subject to drug testing should treat it as a banned substance.
It is most often discussed alongside BPC-157 in recovery, soft-tissue, and performance contexts rather than as a mainstream treatment.
Because it is largely a research chemical with an unregulated supply chain, clinician oversight, sourcing transparency, and honest discussion of the limited evidence matter more than the peptide name.
This page is informational only — it does not diagnose, prescribe, recommend TB-500, or provide dosing guidance.

Clear intro

TB-500 pages usually attract users comparing performance and recovery clinics, often alongside BPC-157. What matters is whether a clinic can explain supervision, regulatory status, rationale, and realistic recovery expectations rather than simply name-dropping the peptide.

Who this is for

This page is useful for patients comparing recovery-focused clinics, performance-oriented providers, and rehabilitation-related listings where TB-500 appears in public treatment metadata — and for athletes who need to understand its anti-doping status.

What to ask before choosing a clinic

How do you decide between TB-500, BPC-157, or simpler alternatives?
What safety monitoring and review are included?
How should I think about evidence quality and expectations?

Pricing and red flags

TB-500 pricing often resembles other recovery-oriented peptide discussions, but real cost depends on whether the clinic bundles assessment, physician review, and combined protocols.

Clinics presenting TB-500 as low-risk or outcome-guaranteed.
No discussion of evidence limits, regulatory status, or the WADA ban.
No clear follow-up plan.

What is TB-500?

TB-500 is a synthetic peptide based on an active fragment of thymosin beta-4, a naturally occurring protein involved in cell migration and tissue repair. It is not a licensed medicine. In the United Kingdom the MHRA treats TB-500 as an unlicensed substance that cannot be marketed or supplied for human use, and it is generally sold only as a 'research chemical'. In the United States it is not FDA-approved and has no completed human efficacy trials. It is also prohibited in sport at all times under the World Anti-Doping Agency (WADA) list, where it has appeared since 2011. On clinic directories it usually shows up in recovery and performance contexts, frequently next to BPC-157.

How it works

Thymosin beta-4, the protein TB-500 is derived from, is involved in regulating actin — a building block of cells — and in processes linked to cell movement and tissue repair. Most of what is described about TB-500 comes from animal and laboratory research rather than robust human trials, so mechanism descriptions should not be read as proven clinical results. For someone comparing clinics, the more useful question is whether a provider explains the limits of the human evidence and why TB-500 is being discussed at all.

Typical use cases

Recovery and rehabilitation discussions, usually framed around soft-tissue or general repair and often paired with BPC-157.
Performance-oriented provider listings — though athletes should note the WADA prohibition before anything else.
Longevity or regenerative settings where it appears as one element of a broader, clinician-led plan rather than a standalone fix.

Cost overview

TB-500 is rarely a standalone priced item; it is usually folded into a wider recovery or regenerative programme, sometimes combined with BPC-157. That makes clinician involvement, monitoring, and sourcing transparency more meaningful comparison points than the headline figure. See the peptide therapy cost guide.

What to expect from clinics

A credible clinic should be clear that TB-500 is not a licensed medicine, that evidence is largely preclinical, and that it is banned in tested sport.
Expect a proper assessment of your history and goals, plus a clear explanation of sourcing, supervision, and follow-up before any protocol is discussed.
Be cautious if a provider presents TB-500 as low-risk or outcome-guaranteed, or cannot explain its regulatory status.

Safety considerations

Because TB-500 is not an approved medicine, its long-term safety in humans has not been established through large clinical trials, and product quality varies across an unregulated supply chain. It is also banned in tested sport. Anyone considering it should do so only with a licensed clinician who can explain the evidence limits, regulatory and anti-doping status, and possible risks for their situation. This page does not recommend TB-500 and does not provide dosing or administration guidance.

Compare this with semaglutide vs tirzepatide or move into city pages such as Los Angeles and New York if you want to compare how providers frame these treatments locally.

Frequently asked questions about TB-500

Is TB-500 legal in the UK?

TB-500 is not licensed as a medicine in the UK. The MHRA treats it as an unlicensed substance, so it cannot legally be marketed or supplied for human use, although it is sold as a 'research chemical' not intended for human consumption.

Is TB-500 FDA-approved in the US?

No. TB-500 is not FDA-approved for any human use and has no completed human efficacy trials. It remains an unapproved, investigational substance accessed mainly through research-chemical suppliers.

Is TB-500 banned in sport?

Yes. TB-500 is prohibited at all times under the World Anti-Doping Agency (WADA) list and has been since 2011. Any athlete subject to drug testing should treat it as a banned substance.

What is the evidence behind TB-500?

Most research on TB-500 comes from animal and laboratory studies of tissue repair. High-quality human clinical trials are lacking, so claims of proven benefits in people should be treated with caution.

Is TB-500 the same as BPC-157?

No. They are different peptides, although clinics often discuss them together in recovery contexts. If you are comparing them, see our BPC-157 vs TB-500 comparison.

Does Peptide Clinic Finder sell or recommend TB-500?

No. Peptide Clinic Finder is an informational directory. We do not sell TB-500, provide medical advice, or recommend its use — we help you compare how clinics position and supervise treatments so you can make an informed decision with a licensed clinician.

Related comparisons: BPC-157 vs TB-500, TB-500 vs GHK-Cu.

Next step

Compare Providers and Next Steps

If you are considering this treatment, compare providers, review your options, and choose the path that best fits your goals and preferred level of care.

Compare Providers Get Matched Browse city clinics

Related TB-500 pages

Move from peptide research into clinic comparisons, guides, and matching.

Find peptide therapy near you BPC-157 vs TB-500 TB-500 vs GHK-Cu The Catalyst Clinic LiveNow Longevity Menon Health Nūūtro HUM2N Reborne Longevity

Not sure whether local clinics or online options are the better fit? compare providers or use our matching tool to find the right next step. If you want a broader market view first, find a peptide clinic near you.

Clinics offering TB-500

RecommendedVerified

The Catalyst Clinic

London, United Kingdom5.0

Doctor-led peptide advisory consultations in central London. Every protocol is built around comprehensive bloodwork and personally led by Dr Ethan Hausman-Marquis, who reports a PhD from the Karolinska Institute, with compounds sourced from GMP-certified, EMA-regulated pharmacies.

Doctor-led clinical governance

Peptide Therapy Regenerative Medicine Longevity

From £600